LEGAL PROCEEDINGS - Intellectual Property (Details)					1 Months Ended			9 Months Ended
	Nov. 02, 2023 defendant	Jul. 21, 2022	Sep. 10, 2021	Mar. 26, 2020	Jan. 31, 2023	Apr. 30, 2021	Mar. 31, 2021 defendant proceeding	Sep. 30, 2023 lawsuit defendant
Norwich Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period				30 months	30 months
Taro Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period		30 months
MSN Laboratories Private Ltd. Litigation
Loss Contingencies [Line Items]
Stay of approval, period						30 months
Aurobindo Pharma Limited Litigation
Loss Contingencies [Line Items]
Stay of approval, period					30 months
Xifaxan® Litigation with Curia IP Holdings, LLC
Loss Contingencies [Line Items]
Number of consolidated lawsuits | lawsuit								1
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants								13
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants								2
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants							19
Number of proceedings | proceeding							16
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb | Subsequent Event
Loss Contingencies [Line Items]
Number of defendants	1
Lumify Paragraph I V Proceedings Slayback ANDA Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Stay of approval, period			30 months